Executive Order Looks to Spur Research, Access to Psychedelics for Mental Health Treatment
- April 24, 2026
- Written by AHLA Legal Staff
President Trump signed a new executive order that allocates $50 million to advance research into psychedelics therapies, including ibogaine compounds, for treating serious mental illness.
ARTICLE TAGS
You must be logged in to access this content.